報價延遲最少15分鐘:2026/03/02 05:39 EST
盤前時段
|
||||
|
3.49 
|
|
|
常規時段 (已結束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.51
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.64/-1.12
|
|
企業價值
153.73M
|
| 資產負債 |
|
每股賬面淨值
3.33
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
25.98M
|
|
每股收益
--
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. |
